期刊文献+

人类乳头状瘤病毒分型检测在宫颈癌筛查中的临床研究 被引量:15

Clinical efficacy of human papillomavirus (HPV) genotyping in screening for cervical disorders
原文传递
导出
摘要 目的 探讨人类乳头状瘤病毒(human papillomavirus,HPV)基因分型检测在宫颈病变诊断中的临床应用价值.方法 选取2010年1月至2012年12月在北京大学第一医院妇产科就诊的1715例患者作为研究对象,所有患者均行宫颈脱落细胞学检查、HPV分型检测及阴道镜检查下行多点活检,并最终经组织病理学检查诊断为宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN).分析HPV分型检查在宫颈癌筛查诊断中临床应用价值.结果 1715例CIN患者HPV检出率排名前五位的依次是HPV16、58、52、33、31;CIN2+(包括CIN2/CIN3/原位腺癌/宫颈癌,以下简称CIN2+)患者中前五位依次是HPVI6、58、33、52、31;其中CIN2+中细胞学未见上皮内病变细胞和恶性细胞(negative for intraepithelial lesion or malignancy,NILM)患者中,Logistic回归分析结果显示HPV16、33和18型阳性致CIN2+风险性较大,回归系数OR分别为5.031(P=0.000)、2.375 (P=0.000)和1.598(P =0.027).宫颈脱落细胞学为非典型鳞状上皮细胞(atypical squamous cells of undetermined significance,ASCUS),伴随HPV16、58型阳性,发生CIN2+风险性较大,回归系数OR分别为5.139(P=0.000)和2.096(P=0.025).宫颈脱落细胞学为低度鳞状上皮内病变(low squamous intraepithelial lesion,LSIL),伴随HPV16、33、52型CIN2+风险性较大,回归系数OR分别为5.774(P =0.000)、3.368(P =0.000)和1.747(P=0.034).结论 HPV分型检测在宫颈癌筛查中具有重要作用,是指导细胞学阴性、ASCUS和LSIL患者临床处理时的重要参考指标,尤其是当HPV16型阳性时. Objective To evaluate the clinical value of HPV genotyping in diagnosis of cervical lesions.Methods Totally 1715 patients seen in Department of Obstetrics and Gynecology,Peking University First Hospital from January 2010 to December 2012 were chosen to be evaluated.All the patients experienced cervical Liquid-based cytology test,HPV genotyping and multiple punch biopsy during colposcopy and they were confirmed of cervical intraepithelial neoplasia (CIN) through histopathological examination.The clinical efficacy of HPV genotyping was evaluated.Results HPV 16,58,52,33 and 31 were the first five types detected in all of the 1715 patients.The first five types detected in the patients with CIN2 + (including CIN2/CIN3/adenocarcinoma in situ/cervical cancer) were HPV 16,58,33,52 and 31.Logistic regression analysis showed that in the CIN2 + patients who were negative for intraepithelial lesion or malignancy (NILM),those with positive HPV 16,33 and 18 had higher risk of CIN2 +,with the regression coefficient OR 5.031 (P =0.000),2.375 (P =0.000) and 1.598 (P =0.027).The cervical liquid-based cytology showed that there was a higher risk of CIN2 + for atypical squamous cells of undetermined significance (ASCUS) with positive HPV 16 and 18,and the regression coefficients OR were 5.139 (P =0.000) and 2.096 (P =0.025),respectively ; and the low-grade squamous intraepithelial lesion (LSIL) with positive HPV 16,33 and 52 had higher risk of CIN2 +,the regression coefficients OR were 5.774(P =0.000),3.368(P =0.000) and 1.747(P =0.034).Conclusion HPV genotyping is significantly useful for cervical screening.It is an important parameter for directing the clinical treatment in ASCUS and LSIL patients with negative cytology results,especially HPV 16 positive patients need to be further evaluated.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2014年第6期429-432,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 乳头状瘤病毒 基因型 宫颈上皮内瘤样病变 宫颈肿瘤 Papillomavirus,human Genotype Cervical intraepithelial neoplasia Cervix neoplasms
  • 相关文献

参考文献1

二级参考文献8

共引文献10

同被引文献115

  • 1赵巍.阴道镜检查结合宫颈细胞学ASCUS检查在排除宫颈癌方面的意义[J].内蒙古民族大学学报(自然科学版),2013,28(5):587-588. 被引量:1
  • 2International Agency for Research on Cancer. GLOBOCAN 2012 : estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer/World Health Organization, 2012. 被引量:1
  • 3Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol, 2012, 137:516-542. doi: 10. 1309/ AJCPTGD94EVRSJCG. 被引量:1
  • 4Xu HH, Shi WW, Lin A, et al. HLA-G 3" untranslated region polymorphisms influence the susceptibility for human papillomavirus infection. Tissue Antigens, 2014, 84:216-222. doi: 10. llll/tan. 12359. 被引量:1
  • 5De Sanjose S, Quint WG, Alemany L. Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cross-sectional worldwide study. cervical cancer: a retrospective Lancet Oncol, 2010, 11 : 1048-1066. doi: 10. 1016/S1470-2045(10)70230-8. 被引量:1
  • 6Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grMe 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst, 20|0, 102:1478-1d88. doi: 10. 1093/jnci/djq356. 被引量:1
  • 7Castle PE, Stoler MH, Wright TC, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPVI6 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol, 2011, 12: 880-890. doi: 10. 1016/S1470-2045 ( ll ) 70188-7. 被引量:1
  • 8De Sanjose S, Quint WG, Alemany L, et al. Hunrn papitlomavius genotype attribution in invasive cervical cancer: a retrospeetive cross-sectional worldwide study. Lancet Oncol, 2010,11: 1048- 1056. doi : 10. 1016/$1470-2045 ( 10)70230-8. 被引量:1
  • 9Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concmTent testing for human papillomavirus and cervical cytology : a population-based study in routine clinical practice. Lancet Oneol, 201 !, 12 : 663-672. doi: 10. 1016/S1470-2045 ( 11 )70145-0. 被引量:1
  • 10Ronco G, Giorgi-Rossi P, Carozzi F, et al; New Technologies for Cervical Cancer Screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepitheli neoplasia: a randomised controlled trial. Lancet Oncol, 2010, 11 : 249-257. doi: 10. 1016/S1470-2045 (09) 70360-2. 被引量:1

引证文献15

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部